MDGL
Madrigal Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $9.57B | Price | $418.90 |
| Volume | 385.62K | Change | -2.02% |
| P/E Ratio | -20.5 | Open | $428.50 |
| Revenue | $180.1M | Prev Close | $427.52 |
| Net Income | $-465.9M | 52W Range | $265.00 - $463.63 |
| Div Yield | N/A | Target | $501.38 |
| Overall | 53 | Value | 40 |
| Quality | 47 | Technical | 72 |
No chart data available
Stock Overview
Updated DailyMadrigal Pharmaceuticals Inc. (MDGL) is a leading Healthcare company in the Biotechnology industry, currently trading at $418.90 with a market capitalization of $9.57 billion. The stock is positioned in the upper portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows MDGL with a volume of 386K shares. The stock opened up 0.23% from yesterday's close of $427.52. Current analyst estimates project earnings of $-8.33 per share for this year, with next year targeting $4.78.
MDGL demonstrates weak technical indicators based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OMHE, OILS-CA, OGN, ONPH.
Key investment considerations for MDGL include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 19.7%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 03:52 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MDGL | $418.90 | -2.0% | 385.62K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Madrigal Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW